The EUs drug regulator, the European Medicines Agency (EMA), said that it had given the green light to two vaccines that target the omicron variant of COVID-19.The vaccines were developed by the US-German partnership BioNTech-Pfizer and by the US company Moderna.The vaccines are the first to target the omicron variant